146 related articles for article (PubMed ID: 37334096)
1. Trends in hospital admissions and mortality among inflammatory bowel disease patients with substance use disorder: a 10-year United States nationwide analysis.
Fatakhova K; Patel P; Inayat F; Dhillon R; Ali H; Taj S; Nawaz G; Afzal A; Rehman AU; Afzal MS; Khan R; Ishtiaq R; Jones L; Rajapakse R
Proc (Bayl Univ Med Cent); 2023; 36(4):427-433. PubMed ID: 37334096
[TBL] [Abstract][Full Text] [Related]
2. Substance abuse and inpatient outcomes in inflammatory bowel disease hospitalizations in the United States: a propensity matched analysis.
Patel P; Ali H; Manickam S; Pamarthy R; Fatakhova K; Rajapakse R
Ann Gastroenterol; 2023; 36(1):32-38. PubMed ID: 36593809
[TBL] [Abstract][Full Text] [Related]
3. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
[No Abstract] [Full Text] [Related]
4. Predictors of Hospital-related Outcomes of COVID-19 Infection in Patients With Inflammatory Bowel Disease in the Early Pandemic Phase: A Nationwide Inpatient Database Survey.
Naseem K; Sohail A; Quang Nguyen V; Khan A; Cooper G; Lashner B; Katz J; Cominelli F; Regueiro M; Mansoor E
Inflamm Bowel Dis; 2023 Sep; ():. PubMed ID: 37725039
[TBL] [Abstract][Full Text] [Related]
5. A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations.
Dahiya DS; Kichloo A; Wani F; Singh J; Solanki D; Shaka H
Intest Res; 2022 Jul; 20(3):342-349. PubMed ID: 34011019
[TBL] [Abstract][Full Text] [Related]
6. Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil.
Guedes ALV; Lorentz AL; Rios LFAR; Freitas BC; Dias AGN; Uhlein ALE; Vieira Neto FO; Jesus JFS; Torres TSN; Rocha R; Andrade VD; Santana GO
World J Gastrointest Pharmacol Ther; 2022 Jan; 13(1):1-10. PubMed ID: 35116179
[TBL] [Abstract][Full Text] [Related]
7. Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States.
Galoosian A; Rezapour M; Liu B; Bhuket T; Wong RJ
J Clin Gastroenterol; 2020 Aug; 54(7):e63-e72. PubMed ID: 31008866
[TBL] [Abstract][Full Text] [Related]
8. Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
Barber GE; Hendler S; Okafor P; Limsui D; Limketkai BN
Inflamm Bowel Dis; 2018 Jul; 24(8):1849-1856. PubMed ID: 29722832
[TBL] [Abstract][Full Text] [Related]
9. Influence of nonalcoholic fatty liver disease on inflammatory bowel disease hospitalizations in the United States.
Soni A; Yekula A; Dahiya DS; Sundararajan R; Dutta P; Singh Y; Cheng CI; Abraham G
Ann Gastroenterol; 2023; 36(6):646-653. PubMed ID: 38023970
[TBL] [Abstract][Full Text] [Related]
10. Time-trends in hospitalizations with cannabis use disorder: A 17-year U.S. national study.
Singh JA
Subst Abus; 2022; 43(1):408-414. PubMed ID: 34214395
[No Abstract] [Full Text] [Related]
11. Racial differences in the outcomes of IBD hospitalizations: a national population-based study.
Asotibe JC; Akuna E; Williams D; Busari OA; Edigin E; Achebe I; Asotibe BM; Trick W; Mishra S
Int J Colorectal Dis; 2022 Jan; 37(1):221-229. PubMed ID: 34694440
[TBL] [Abstract][Full Text] [Related]
12. Hospital costs, length of stay and prevalence of hip and knee arthroplasty in patients with inflammatory bowel disease.
Ehrenpreis ED; Zhou Y
World J Gastroenterol; 2017 Jul; 23(26):4752-4758. PubMed ID: 28765696
[TBL] [Abstract][Full Text] [Related]
13. Increasing Rates of Infective Endocarditis in Patients with Inflammatory Bowel Disease.
Shah-Khan SM; Shah-Khan SM; Alqahtani F; Kupec JT
Cureus; 2020 Feb; 12(2):e6919. PubMed ID: 32190474
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Annual Cost of Substance Use Disorder in US Hospitals.
Peterson C; Li M; Xu L; Mikosz CA; Luo F
JAMA Netw Open; 2021 Mar; 4(3):e210242. PubMed ID: 33666661
[TBL] [Abstract][Full Text] [Related]
15. Contemporary Trends in Hospitalizations for Comorbid Chronic Liver Disease and Substance Use Disorders.
Desai AP; Greene M; Nephew LD; Orman ES; Ghabril M; Chalasani N; Menachemi N
Clin Transl Gastroenterol; 2021 Jun; 12(6):e00372. PubMed ID: 34142663
[TBL] [Abstract][Full Text] [Related]
16. Impact of atrial fibrillation on inflammatory bowel disease hospitalizations-a nationwide retrospective study.
Kichloo A; Dahiya DS; Shaka H; Jamal S; Khan MZ; Wani F; Mehboob A; Kanjwal K
Proc (Bayl Univ Med Cent); 2021; 34(6):673-677. PubMed ID: 34732983
[TBL] [Abstract][Full Text] [Related]
17. Time trends in hospitalizations with anxiolytic, sedative, or hypnotic drug use disorder: a 17-year U.S. national study.
Singh J
J Addict Dis; 2022; 40(1):4-11. PubMed ID: 33884947
[TBL] [Abstract][Full Text] [Related]
18. Impact of recurrent hospitalization for
Venkat PG; Nguyen NH; Luo J; Qian AS; Khanna S; Singh S
Therap Adv Gastroenterol; 2022; 15():17562848221141501. PubMed ID: 36518884
[TBL] [Abstract][Full Text] [Related]
19. Nationwide Trends in Hospitalizations and Outcomes of Pulmonary Circulation Disorders Among Patients With Cannabis Use Disorder in the United States.
Jain A; Gandhi Z; Desai R; Mansuri U; Rizvi B; Alvarez M; Gupta P
Cureus; 2022 Mar; 14(3):e22897. PubMed ID: 35399488
[TBL] [Abstract][Full Text] [Related]
20. National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014-2018.
Suen LW; Makam AN; Snyder HR; Repplinger D; Kushel MB; Martin M; Nguyen OK
J Gen Intern Med; 2022 Aug; 37(10):2420-2428. PubMed ID: 34518978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
